HIV-1 Reverse Transcriptase
Assets acting on this target.
- Class
- Nucleoside reverse transcriptase translocation inhibitor (NRTTI)
By indication
Related mechanisms
HIV-1 Reverse Transcriptase drugs compared
4 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Doravirine/islatravir (Idvynso)Idvynso | Merck & Co. | small molecule | Approved | Approved in HIV |
| Alimatravir | Merck & Co. | small molecule | Phase 3 | Phase 3 in HIV; Phase 3 in HIV Pre-Exposure Prophylaxis |
| Islatravir | Merck & Co. | small molecule | Phase 3 | Phase 3 in HIV |
| Islatravir/lenacapavir | Gilead Sciences, Merck & Co. | small molecule | Phase 3 | Phase 3 in HIV |